Kensuke Usuki

24PUBLICATIONS
160CO-AUTHORS
Haematological tumoursPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Epigenetics (incl. genome methylation and epigenomics)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Jul 29, 2026
Long-term efficacy and safety of romiplostim plus immunosuppressive therapy as first-line treatment in patients with aplastic anaemia: 2-year interim analysis of observational study of two clinical trials.

|May 28, 2026
Long-term outcomes of low-dose dasatinib in older patients with chronic myeloid leukemia in chronic phase: an extended follow-up of the DAVLEC phase 2 trial.

|Jan 04, 2026
Phase II study of the triple combination of rabbit ATG, ciclosporin and eltrombopag in patients with transfusion-dependent aplastic anaemia: West Japan Hematology Study Group (W-JHS) AA02 trial.

Fumi Nakamura, Ken Ishiyama, Ritsuro Suzuki

|Aug 04, 2025
Addition of romiplostim to immunosuppressive therapy as first-line treatment for patients with aplastic anemia.

Jong Wook Lee, Jun Ho Jang, Hirohito Yamazaki

|Dec 23, 2024
Genetic analysis of myeloid neoplasms with der(1;7)(q10;p10).

Rurika Okuda, Yotaro Ochi, Ryunosuke Saiki

|Mar 27, 2024
A phase 1/2 study of NS-87/CPX-351 (cytarabine and daunorubicin liposome) in Japanese patients with high-risk acute myeloid leukemia.

Kensuke Usuki, Toshihiro Miyamoto, Takuji Yamauchi

Pageof 4

Frequent Collaborators

4 joint publications

Shigeru Chiba

3 joint publications

Seishi Ogawa

3 joint publications

Ryunosuke Saiki

3 joint publications

Satoru Miyano